Q1 2026 Accendra Health Inc Earnings Call Transcript
Key Points
- Accendra Health Inc (ACH) successfully completed its transition to a standalone, home-based care company, enhancing its focus and operational efficiency.
- The company reported strong year-over-year growth in its sleep therapy category, driven by initiatives like the Sleep Journey program and the new Sleep Center of Excellence.
- Accendra Health Inc (ACH) secured a multi-year extension with its largest commercial payor for soft goods, providing business certainty for the future.
- The company executed a comprehensive balance sheet optimization transaction, significantly reducing total debt and extending maturities, which strengthens its financial position.
- Accendra Health Inc (ACH) maintained a diversified commercial payor portfolio with no major renewals on the horizon, ensuring stability in its revenue streams.
- The company experienced a 6.8% revenue decline in the first quarter, primarily due to the exit from a large commercial payor.
- Accendra Health Inc (ACH) faced challenges with lower year-over-year collection rates, inflationary product cost increases, and higher health benefit expenses.
- The diabetes category underperformed expectations, with growth in insulin pumps not fully offsetting a drop in continuous glucose monitors (CGMs).
- The company anticipates higher annualized cash interest expenses by about $40 million due to refinancing activities, impacting free cash flow.
- Accendra Health Inc (ACH) continues to face seasonal cash flow softness, with free cash flow slightly negative in the first quarter.
Hello. Good morning, and thank you for standing by. Welcome to the Accendra Health's first quarter 2026 earnings conference call. Please be advised that today's conference call is being recorded. (Operator Instructions)
I would now like to hand the conference over to your first speaker today, Will Parrish, Vice President, Strategy, Corporate Development, and Investor Relations. Please go ahead.
Thank you, operator, and good morning, everyone. I'd like to welcome you to Accendra Health's first quarter earnings call. Our comments on the call will be focused on the financial results of the first quarter of 2026, all of which are included in today's press release. The press release, along with the first quarter 2026 supplemental slides, which we will refer to throughout the call, are posted in the Investor Relations section of our website.
Please note that during the call, we will make forward-looking statements that reflect the current views
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
